Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
The Oncologist|April 11, 2014
Identification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new eraPatrick G JohnstonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Role of genomic markers in colorectal cancer treatmentWendy L Allen, Patrick G JohnstonNature Reviews. Clinical Oncology|December 17, 2009
Genomic markers for decision making: what is preventing us from using markers?Vicky M Coyle, Patrick G JohnstonPharmacogenomics|September 7, 2005
Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancerWendy L Allen, Patrick G JohnstonClinical Colorectal Cancer|March 7, 2003
Predictive markers for colorectal cancer: current status and future prospectsDaniel B Longley, Ultan McDermott, Patrick G JohnstonStem Cells (Dayton, Ohio)|November 29, 2002
EPO's alter ego: erythropoietin has multiple actionsTerence R Lappin, A Peter Maxwell, Patrick G JohnstonBiochimica Et Biophysica Acta|September 16, 2006
Drug resistance, predictive markers and pharmacogenomics in colorectal cancerDaniel B Longley, Wendy L Allen, Patrick G JohnstonNature Reviews. Cancer|May 2, 2003
5-fluorouracil: mechanisms of action and clinical strategiesDaniel B Longley, D Paul Harkin, Patrick G JohnstonCurrent Opinion in Pharmacology|June 6, 2006
Predicting the outcome of chemotherapy for colorectal cancerWendy L Allen, Vicky M Coyle, Patrick G JohnstonPageof 11